Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjects
Background: Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown. Objectives: To examine the effect of different levels of ketamine use on psychotic disorders and...
Saved in:
Published in | The American journal of drug and alcohol abuse Vol. 45; no. 3; pp. 276 - 284 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
04.05.2019
Taylor & Francis Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown.
Objectives: To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects.
Methods: A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers.
Results: Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence.
Conclusions: The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males. |
---|---|
AbstractList | Background: Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown.
Objectives: To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects.
Methods: A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers.
Results: Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence.
Conclusions: The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males. Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown.BACKGROUNDRepeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown.To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects.OBJECTIVESTo examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects.A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers.METHODSA cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers.Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence.RESULTSBoth methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence.The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males.CONCLUSIONSThe combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males. Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown. To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects. A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers. Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence. The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males. Background: Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown.Objectives: To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects.Methods: A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers.Results: Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence.Conclusions: The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males. |
Author | Yang, Cheng Liu, Mengqi Shen, Yidong Dong, Huixi Liu, Liang Hao, Wei |
Author_xml | – sequence: 1 givenname: Huixi surname: Dong fullname: Dong, Huixi organization: Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health – sequence: 2 givenname: Cheng surname: Yang fullname: Yang, Cheng organization: Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health – sequence: 3 givenname: Yidong surname: Shen fullname: Shen, Yidong organization: Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health – sequence: 4 givenname: Liang surname: Liu fullname: Liu, Liang organization: Wuxi Mental Health Center, Nanjing Medical University – sequence: 5 givenname: Mengqi surname: Liu fullname: Liu, Mengqi organization: Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health – sequence: 6 givenname: Wei surname: Hao fullname: Hao, Wei email: weihao57@csu.edu.cn organization: Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30640573$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUuP1DAQhC20iJ1d-AkgS1w4kMHP2BEX0Gp5SCtxgbPlJG3GQ2wH2xGaf09GM3PZA5y6D19Vl7pu0FVMERB6ScmWEk3eEdJJ1nVkywjVWyplp0X3BG0o6VTT6Y5eoc2RaY7QNbopZU_IiirxDF1z0goiFd-gn_fOwVALTg7_gmqDj4CXAjhFPJfDsEvVD3j0JeURcsE2jrgcwlxTKNhHHOwEb3GAurNh3p0NmhFmiCPEisvS74_-z9FTZ6cCL87zFv34dP_97kvz8O3z17uPD80gGKmNplK73rYgWteveUnb9W5QoARXLbhRCSc5VevCBR97RqHVwJjWAMAElfwWvTn5zjn9XqBUE3wZYJpshLQUw6jquGyZUCv6-hG6T0uOazrDGOGScd3SlXp1ppY-wGjm7IPNB3N54Qq8PwFDTqVkcGbw1VafYs3WT4YScyzMXAozx8LMubBVLR-pLwf-p_tw0vnoUg72T8rTaKo9TCm7bOPgi-H_tvgLw9GsNw |
CitedBy_id | crossref_primary_10_2174_1570159X19666210215121428 |
Cites_doi | 10.1016/j.joca.2016.01.008 10.1126/science.2563176 10.1016/j.drugalcdep.2017.01.021 10.1097/00000542-199704000-00021 10.1196/annals.1316.036 10.1016/j.taap.2007.10.017 10.1093/schbul/sbs075 10.1016/j.jpsychires.2014.02.010 10.1016/j.annepidem.2013.07.012 10.1186/s12888-017-1346-7 10.1016/S0140-6736(09)60660-7 10.1016/j.psychres.2014.11.077 10.15288/jsad.2012.73.938 10.1016/j.drugalcdep.2013.12.011 10.1097/00005053-199908000-00001 10.1196/annals.1316.035 10.1016/S0006-3223(00)00976-8 10.1177/0269881113512909 10.1016/j.psychres.2016.01.023 10.3389/fpubh.2013.00061 10.1002/syn.890190205 10.1016/j.addbeh.2012.06.024 10.1016/j.brainres.2014.10.044 10.1016/j.jpainsymman.2011.01.001 10.1016/S0376-8716(02)00243-0 10.1001/archpsyc.62.9.985 |
ContentType | Journal Article |
Copyright | 2018 Taylor & Francis Group, LLC. 2018 2018 Taylor & Francis Group, LLC. |
Copyright_xml | – notice: 2018 Taylor & Francis Group, LLC. 2018 – notice: 2018 Taylor & Francis Group, LLC. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QJ 7U3 BHHNA K7. K9. 7X8 |
DOI | 10.1080/00952990.2018.1559849 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Applied Social Sciences Index & Abstracts (ASSIA) Social Services Abstracts Sociological Abstracts ProQuest Criminal Justice (Alumni) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) ProQuest Criminal Justice (Alumni) Social Services Abstracts Applied Social Sciences Index and Abstracts (ASSIA) Sociological Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Social Welfare & Social Work |
EISSN | 1097-9891 |
EndPage | 284 |
ExternalDocumentID | 30640573 10_1080_00952990_2018_1559849 1559849 |
Genre | Article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National Key R&D Program of China grantid: 2017YFC3140401 – fundername: National 973 Program grantid: 2015CB553500 |
GroupedDBID | --- 00X 03L 0BK 0R~ 123 23M 2QV 36B 4.4 5RE 6J9 AALUX AAMIU AAPUL AAQRR AAWTL ABBKH ABDBF ABEIZ ABIVO ABLCE ABLIJ ABLKL ABUPF ABXYU ACENM ACGEJ ACGFO ACGOD ACHQT ACIEZ ACKLR ACUHS ACVOX ADCVX ADRBQ ADXPE ADZJE AECIN AENEX AEOZL AFKVX AGDLA AGFJD AGRBW AGYJP AHMBA AIAGR AIJEM AIRBT AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC ASUFR BABNJ BLEHA BOHLJ CCCUG COF CS3 DKSSO DXH EAP EAS EBC EBD EBS EHN EJD EMB EMK EMOBN EPL EPS EPT ESI ESO ESX F5P FEDTE H13 HZ~ KRBQP KSSTO KUULJ KWAYT KYCEM L7B LJTGL M4Z O9- P2P PQQKQ Q~Q RNANH RVRKI RWL SV3 TAE TBQAZ TERGH TFDNU TFL TFW TUROJ TUS U5U V1S WH7 X6Y XSW ~1N AAGDL AAYXX ABWVI ADYSH AFRVT AMPGV CITATION TDBHL .GJ 34G 39C 53G 5VS AADGC AALIY AAPXX AAQQT ABGNL ACKFH ACWGZ ADPSL ADVEQ AEIQB AELXL AETHL AEXKJ AFFNX AFLJA AGXXK AI. AIKPT APIUT AWYRJ B0M BTKSN C1A CAG CGR COGVJ CUY CVF ECM EIF HAMGP HVGLF H~9 LSO M44 NPM VH1 VQP YYQ ZGI ZXP 7QJ 7U3 BHHNA K7. K9. TASJS 7X8 |
ID | FETCH-LOGICAL-c420t-8158fba6e46fb000069bfc7e74376efd74f5317fd7343db21e68e2288eee24153 |
ISSN | 0095-2990 1097-9891 |
IngestDate | Fri Jul 11 00:09:34 EDT 2025 Thu Aug 07 15:21:52 EDT 2025 Thu Apr 03 06:59:36 EDT 2025 Tue Jul 01 01:49:29 EDT 2025 Thu Apr 24 22:56:11 EDT 2025 Wed Dec 25 09:08:09 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | DSM-IV psychotic symptoms psychotic disorders ketamine methamphetamine |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c420t-8158fba6e46fb000069bfc7e74376efd74f5317fd7343db21e68e2288eee24153 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 30640573 |
PQID | 2203523861 |
PQPubID | 48364 |
PageCount | 9 |
ParticipantIDs | proquest_journals_2203523861 pubmed_primary_30640573 informaworld_taylorfrancis_310_1080_00952990_2018_1559849 proquest_miscellaneous_2179356247 crossref_citationtrail_10_1080_00952990_2018_1559849 crossref_primary_10_1080_00952990_2018_1559849 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-05-04 |
PublicationDateYYYYMMDD | 2019-05-04 |
PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-04 day: 04 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York |
PublicationTitle | The American journal of drug and alcohol abuse |
PublicationTitleAlternate | Am J Drug Alcohol Abuse |
PublicationYear | 2019 |
Publisher | Taylor & Francis Taylor & Francis Ltd |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Ltd |
References | CIT0030 CIT0010 CIT0012 CIT0011 CIT0014 CIT0013 CIT0016 CIT0015 CIT0018 CIT0019 CIT0021 CIT0020 World Drug Report (CIT0001) 2016 CIT0023 CIT0022 First M (CIT0017) 2003 Annual Report on Drug Control in China (CIT0003) 2017 CIT0025 CIT0024 CIT0005 CIT0027 CIT0004 CIT0026 CIT0007 CIT0029 CIT0006 CIT0028 Annual Report on Drug Control in China (CIT0002) 2004 CIT0009 CIT0008 |
References_xml | – ident: CIT0020 doi: 10.1016/j.joca.2016.01.008 – ident: CIT0030 doi: 10.1126/science.2563176 – ident: CIT0015 doi: 10.1016/j.drugalcdep.2017.01.021 – volume-title: National Narcotic Control Commission (NNCC) year: 2017 ident: CIT0003 – ident: CIT0026 doi: 10.1097/00000542-199704000-00021 – ident: CIT0025 doi: 10.1196/annals.1316.036 – ident: CIT0028 doi: 10.1016/j.taap.2007.10.017 – ident: CIT0006 doi: 10.1093/schbul/sbs075 – ident: CIT0014 doi: 10.1016/j.jpsychires.2014.02.010 – ident: CIT0009 doi: 10.1016/j.annepidem.2013.07.012 – volume-title: Structured clinical interview for DSM-IV-TR axis I disorders year: 2003 ident: CIT0017 – volume-title: United nations office on drugs and crime. United Nations publication, Sales No. E.16.XI.7 year: 2016 ident: CIT0001 – ident: CIT0010 doi: 10.1186/s12888-017-1346-7 – ident: CIT0018 doi: 10.1016/S0140-6736(09)60660-7 – ident: CIT0004 doi: 10.1016/j.psychres.2014.11.077 – ident: CIT0016 doi: 10.15288/jsad.2012.73.938 – ident: CIT0011 doi: 10.1016/j.drugalcdep.2013.12.011 – ident: CIT0019 doi: 10.1097/00005053-199908000-00001 – ident: CIT0023 doi: 10.1196/annals.1316.035 – volume-title: National Narcotic Control Commission (NNCC) year: 2004 ident: CIT0002 – ident: CIT0022 doi: 10.1016/S0006-3223(00)00976-8 – ident: CIT0005 doi: 10.1177/0269881113512909 – ident: CIT0007 doi: 10.1016/j.psychres.2016.01.023 – ident: CIT0012 doi: 10.3389/fpubh.2013.00061 – ident: CIT0029 doi: 10.1002/syn.890190205 – ident: CIT0013 doi: 10.1016/j.addbeh.2012.06.024 – ident: CIT0024 doi: 10.1016/j.brainres.2014.10.044 – ident: CIT0027 doi: 10.1016/j.jpainsymman.2011.01.001 – ident: CIT0008 doi: 10.1016/S0376-8716(02)00243-0 – ident: CIT0021 doi: 10.1001/archpsyc.62.9.985 |
SSID | ssj0001874 |
Score | 2.213581 |
Snippet | Background: Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a... Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater... |
SourceID | proquest pubmed crossref informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 276 |
SubjectTerms | Adult Amphetamine-Related Disorders Auditory hallucinations Between-subjects design Central Nervous System Stimulants - administration & dosage Central Nervous System Stimulants - adverse effects Clinical interviews Delusions Drug abuse Drug addiction DSM-IV Hallucinations Humans Ketamine Ketamine - administration & dosage Ketamine - adverse effects Male Males Men Methamphetamine Methamphetamine - administration & dosage Methamphetamine - adverse effects Persecutory ideation Psychoses, Substance-Induced - etiology Psychosis psychotic disorders Psychotic symptoms Rehabilitation Substance abuse Symptoms |
Title | Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjects |
URI | https://www.tandfonline.com/doi/abs/10.1080/00952990.2018.1559849 https://www.ncbi.nlm.nih.gov/pubmed/30640573 https://www.proquest.com/docview/2203523861 https://www.proquest.com/docview/2179356247 |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZK98IF8aZQkJEQlyVVk7iOc9xHqwpVyyUV5RTZqc1Gu01WbSIev55x7DwqutqFSxS5dZL2-zIejz3fIPSBESFdrqgTMsIdAlNmhzEuHOCK54dJMlbrSu3zgs6X5PNqsur1fnSzSwoxSn4fzCv5H1ShDXDVWbL_gGxzUWiAc8AXjoAwHO-F8bTdjHElC77RHmOpg_NZnV2VJnoJptLXNGLMu1-bmyLfVLtgN3Yvsa4izQFVewmnLoxbHO9KoeM0u64LG7W5KFlXeGK9LU26IzdVd4-5KNuVn3O79Xdepj_TxtTYYPXZpbQDqBGLrCzht3Sdt62LtDQhBG7bbKRCJ0dNHFNb2BrXcRgAJ0x1rpE80GYtshGYtMzzu-bV1Ir5y-zX-yTDiR5d9YY9NtLrrczIoe7LbF98iWfLxSKOpqvoATryYH7h9dHRyen56awZxHWpwmqh3D5enfylZdkP3WbPrdkTvb196lK5MNFj9MjOPfCJIdIT1JPZUzQ0Cdr4q7xWfCvxR1w35NurZ-i75RjOFa45hgFXnGe44RhuOIaBALjmGE4zrDn2Cd_KMFwz7DlazqbR2dyxxTmchHjjwmHuhCnBqSRUVTMNGgqVBBI80oBKtQ6IAvMewIlP_LXwXEmZ9DzGpJTaa_RfoH6WZ_IVwjDEsnCsFA1VSAjhnHrgicvAJYoKwYIBIvV_GydWuV4XULmO3Ubg1kASa0hiC8kAjZpuN0a65a4OYRe4uKhiZsoUuIn9O_oOa5Rj--rtYs_TasM-o-4AvW8-BvutF-V4JvMSvqNHSJiEEPiZLw07mqfV0QEtWPr6Hr3foIftOzdE_WJbyrfgLxfineX2H5dDvGQ |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+ketamine+use+on+psychotic+disorders+and+symptoms+in+male%2C+methamphetamine-dependent+subjects&rft.jtitle=The+American+journal+of+drug+and+alcohol+abuse&rft.au=Dong%2C+Huixi&rft.au=Yang%2C+Cheng&rft.au=Shen%2C+Yidong&rft.au=Liu%2C+Liang&rft.date=2019-05-04&rft.issn=1097-9891&rft.eissn=1097-9891&rft.volume=45&rft.issue=3&rft.spage=276&rft_id=info:doi/10.1080%2F00952990.2018.1559849&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0095-2990&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0095-2990&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0095-2990&client=summon |